Table 6 Risk factors for TEEs in patients who did not present with TEEs versus those who presented with TEEs (overall period)
No. of TEE (N = 89) | TEE (N = 6) | |
|---|---|---|
Age, mean (range), years | 51.6 (22–77) | 69.0 (62–79) |
Gender, n (%) female | 68 (76.4) | 3 (50) |
Race, n (%) | ||
Asian | 2 (2.2) | 0 (0) |
Black or African American | 5 (5.6) | 0 (0) |
White | 81 (91.0) | 6 (100) |
Other | 1 (1.1) | 0 (0) |
TEE risk factors | ||
Hypertension, n (%) | 31 (34.8) | 5 (83.3) |
Chronic heart failure, n (%) | 1 (1.1) | 1 (16.7) |
Myocardial ischaemia, n (%) | 2 (2.2) | 1 (16.7) |
Dyslipidaemia, n (%) | 4 (4.5) | 2 (33.3) |
Dilation ventricular and left atrial dilation, n (%) | 1 (1.1) | 1 (16.7) |
Obesity, n (%) | 3 (3.4) | 2 (33.3) |
Supraventricular arrhythmia, n (%) | 0 (0.0) | 1 (16.7) |
Hypercholesterolaemia, n (%) | 8 (9.0) | 2 (33.3) |
Osteoporotic fracture, n (%) | 1 (1.1) | 1 (16.7) |
No. of TEE risk factors per patient | ||
0 risk factors | 50 (56.2) | 0 (0) |
1 risk factor | 28 (31.5) | 1 (16.7) |
2 risk factors | 10 (11.2) | 0 (0) |
3 risk factors | 1 (1.1) | 5 (83.3) |
Physician global disease activity (actual), n (%) | ||
Mild | 24 (27.0) | 2 (33.3) |
Moderate | 52 (58.4) | 4 (66.7) |
Severe | 13 (14.6) | 0 (0.0) |
Maximum infusion rate per patient, median (range), mL/kg/min | ||
Pre-introduction of lower infusion rate | 0.12 (0.04–0.12) | 0.12 (0.04–0.12) |
Following introduction of lower infusion rate | 0.04 (0.02–0.08) | 0.04 (0.02–0.08) |
Actual IVIg dose, median (range), g/kg | 1.99 (0.24–2.03) | 1.99 (1.98–2.03) |